Bacterial protein secretion is required for priming of CD8+ T cells specific for the Mycobacterium tuberculosis antigen CFP10
- PMID: 18591224
- PMCID: PMC2519428
- DOI: 10.1128/IAI.00307-08
Bacterial protein secretion is required for priming of CD8+ T cells specific for the Mycobacterium tuberculosis antigen CFP10
Abstract
Mycobacterium tuberculosis infection elicits antigen-specific CD8(+) T cells that are required to control disease. It is unknown how the major histocompatibility complex class I (MHC-I) pathway samples mycobacterial antigens. CFP10 and ESAT6 are important virulence factors secreted by M. tuberculosis, and they are immunodominant targets of the human and murine T-cell response. Here, we test the hypothesis that CFP10 secretion by M. tuberculosis is required for the priming of CD8(+) T cells in vivo. Our results reveal an explicit dependence upon the bacterial secretion of the CFP10 antigen for the induction of antigen-specific CD8(+) T cells in vivo. By using well-defined M. tuberculosis mutants and carefully controlling for virulence, we show that ESX-1 function is required for the priming of CD8(+) T cells specific for CFP10. CD4(+) and CD8(+) T-cell responses to mycobacterial antigens secreted independently of ESX-1 were unaffected, suggesting that ESX-1-dependent phagosomal escape is not required for CD8(+) T-cell priming during infection. We propose that the overrepresentation of secreted proteins as dominant targets of the CD8(+) T-cell response during M. tuberculosis infection is a consequence of their preferential sampling by the MHC-I pathway. The implications of these findings should be considered in all models of antigen presentation during M. tuberculosis infection and in vaccine development.
Figures
Similar articles
-
Mycobacterium tuberculosis ESX-1 system-secreted protein ESAT-6 but not CFP10 inhibits human T-cell immune responses.Tuberculosis (Edinb). 2009 Dec;89 Suppl 1:S74-6. doi: 10.1016/S1472-9792(09)70017-4. Tuberculosis (Edinb). 2009. PMID: 20006311
-
Recombinant Mycobacterium smegmatis expressing an ESAT6-CFP10 fusion protein induces anti-mycobacterial immune responses and protects against Mycobacterium tuberculosis challenge in mice.Scand J Immunol. 2010 Oct;72(4):349-57. doi: 10.1111/j.1365-3083.2010.02448.x. Scand J Immunol. 2010. PMID: 20883320
-
Antigen-specific CD8(+) T cells and protective immunity to tuberculosis.Adv Exp Med Biol. 2013;783:141-63. doi: 10.1007/978-1-4614-6111-1_8. Adv Exp Med Biol. 2013. PMID: 23468108 Free PMC article. Review.
-
Classically restricted human CD8+ T lymphocytes derived from Mycobacterium tuberculosis-infected cells: definition of antigenic specificity.J Immunol. 2001 Jan 1;166(1):439-46. doi: 10.4049/jimmunol.166.1.439. J Immunol. 2001. PMID: 11123322
-
Mycobacterium tuberculosis-specific CD8+ T cells and their role in immunity.Crit Rev Immunol. 2006;26(4):317-52. doi: 10.1615/critrevimmunol.v26.i4.30. Crit Rev Immunol. 2006. PMID: 17073557 Free PMC article. Review.
Cited by
-
Evasion and subversion of antigen presentation by Mycobacterium tuberculosis.Tissue Antigens. 2009 Sep;74(3):189-204. doi: 10.1111/j.1399-0039.2009.01301.x. Epub 2009 Jun 25. Tissue Antigens. 2009. PMID: 19563525 Free PMC article. Review.
-
Immunopeptidomics reveals determinants of Mycobacterium tuberculosis antigen presentation on MHC class I.Elife. 2023 Apr 19;12:e84070. doi: 10.7554/eLife.84070. Elife. 2023. PMID: 37073954 Free PMC article.
-
Prime-boost BCG vaccination with DNA vaccines based in β-defensin-2 and mycobacterial antigens ESAT6 or Ag85B improve protection in a tuberculosis experimental model.Vaccine. 2013 Jan 11;31(4):676-84. doi: 10.1016/j.vaccine.2012.11.042. Epub 2012 Nov 26. Vaccine. 2013. PMID: 23196205 Free PMC article.
-
Leveraging Immunopeptidomics To Study and Combat Infectious Disease.mSystems. 2021 Aug 31;6(4):e0031021. doi: 10.1128/mSystems.00310-21. Epub 2021 Aug 3. mSystems. 2021. PMID: 34342538 Free PMC article.
-
Mycobacterium tuberculosis-specific CD4+ and CD8+ T cells differ in their capacity to recognize infected macrophages.PLoS Pathog. 2018 May 21;14(5):e1007060. doi: 10.1371/journal.ppat.1007060. eCollection 2018 Feb. PLoS Pathog. 2018. PMID: 29782535 Free PMC article.
References
-
- Behr, M. A., M. A. Wilson, W. P. Gill, H. Salamon, G. K. Schoolnik, S. Rane, and P. M. Small. 1999. Comparative genomics of BCG vaccines by whole-genome DNA microarray. Science 2841520-1523. - PubMed
-
- Brodin, P., M. I. de Jonge, L. Majlessi, C. Leclerc, M. Nilges, S. T. Cole, and R. Brosch. 2005. Functional analysis of early secreted antigenic target-6, the dominant T-cell antigen of Mycobacterium tuberculosis, reveals key residues involved in secretion, complex formation, virulence, and immunogenicity. J. Biol. Chem. 28033953-33959. - PubMed
-
- Brodin, P., L. Majlessi, L. Marsollier, M. I. de Jonge, D. Bottai, C. Demangel, J. Hinds, O. Neyrolles, P. D. Butcher, C. Leclerc, S. T. Cole, and R. Brosch. 2006. Dissection of ESAT-6 system 1 of Mycobacterium tuberculosis and impact on immunogenicity and virulence. Infect. Immun. 7488-98. - PMC - PubMed
-
- Brodin, P., I. Rosenkrands, P. Andersen, S. T. Cole, and R. Brosch. 2004. ESAT-6 proteins: protective antigens and virulence factors? Trends Microbiol. 12500-508. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Research Materials
